Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older

NCT06678607 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infectious Disease

Interventions

BIOLOGICAL: Reinovax PCV24 formulation 1
BIOLOGICAL: Reinovax PCV24 formulation 2
BIOLOGICAL: PPSV23
BIOLOGICAL: Placebo

Sponsor

Shanghai Reinovax Biologics Co.,LTD